InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (5 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
5
T+90 hit rate
50%
T+90 mean return
+7.0%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by DeLuca Teresa, Director. Officer active across 3 companies, notably Surgery Partners, Inc.. Aggregated, 17 disclosures have been logged. Split: 5 buys · 5 sells. Total volume traded: €1.5m. Activity tracked since 8 June 2021. The latest transaction was disclosed on 2 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations17 total
17,746 shares0Common StockSEC:0001193125-26-297802:0
11,670 shares@ US$13.710.0076% mcap6.6% of flowCommon StockSEC:0001638833-26-000058:0
35,211 shares0Common StockSEC:0000950170-24-102377:0
36,363 shares0Common StockSEC:0000950170-24-101078:0
6,170 shares@ US$25.937.5% of flowCommon StockSEC:0001638833-24-000121:0
4,192 shares@ US$38.167.6% of flowCommon StockSEC:0001638833-24-000095:0
20,000 shares@ US$24.5024.3% of flowCommon StockSEC:0001638833-22-000137:0
Ideal exit: 18 Aug 2023 (T+270)
4,030 shares@ US$39.700.0083% mcap12.8% of flowCommon StockSEC:0001638833-22-000111:0
1,535 shares@ US$53.500.0041% mcap6.3% of flowCommon StockSEC:0001638833-22-000081:0
5,000 shares@ US$4.0050.0% of flowCommon StockSEC:0001213900-21-064878:0
Ideal exit: 5 Sept 2022 (T+270)
5,000 shares@ US$4.0050.0% of flowCommon StockSEC:0001213900-21-064878
Ideal exit: 5 Sept 2022 (T+270)
2,000 shares@ US$46.704.1% of flowCommon StockSEC:0001638833-21-000138
Ideal exit: 7 May 2022 (T+270)
2,000 shares@ US$46.700.0044% mcap6.7% of flowCommon StockSEC:0001638833-21-000138:0
Ideal exit: 7 May 2022 (T+270)
5,035 shares@ US$63.6713.5% of flowCommon StockSEC:0001638833-21-000130
5,035 shares@ US$63.670.014% mcap22.2% of flowCommon StockSEC:0001638833-21-000130:0
2,633 shares@ US$63.050.0075% mcap11.5% of flowCommon StockSEC:0001638833-21-000128:0
2,633 shares@ US$63.057.0% of flowCommon StockSEC:0001638833-21-000128
17 of 17 declarations
About DeLuca Teresa
Teresa DeLuca serves as a Board Member at Surgery Partners, Inc. and 180 Life Sciences Corp. She brings expertise in business management and market strategy, contributing to the strategic direction of these companies. As a board member, she is involved in key decision-making processes that influence the performance of Surgery Partners and 180 Life Sciences. Her experience in the sector allows her to inform discussions on innovation and growth.
